MediWound (MDWD) Shares Outstanding (Diluted Average) (2018 - 2025)
MediWound (MDWD) recorded quarterly Shares Outstanding (Diluted Average) of $11.4 million in Q4 2025, up 875020.85% quarter-over-quarter from $1300.0 in Q2 2025, and up 14.23% on a YoY basis from $10.0 million in Q4 2024.
MediWound (MDWD) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends
MediWound's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $11.4 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Diluted Average) rose 14.23% year-over-year to $11.4 million; the TTM figure through Dec 2025 stood at $11.4 million (up 14.23% YoY), while the FY2025 annual figure was $11.4 million, up 375364.39% from the prior year.
- Shares Outstanding (Diluted Average) was $11.4 million for Q4 2025 at MediWound, up from $1300.0 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $11.4 million in Q4 2025 to a low of $320.0 in Q2 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $4.8 million across 5 years, with a median of $4.8 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) slumped 82.12% in 2023, then surged 440.62% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $3.9 million in 2021, then gained by 28.13% to $5.0 million in 2022, then jumped by 80.73% to $9.0 million in 2023, then increased by 10.5% to $10.0 million in 2024, then increased by 14.23% to $11.4 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $11.4 million (Q4 2025), $1300.0 (Q2 2025), and $10.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 92.44 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | 11.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.38 Mn |
| Jun 30, 2025 | 1,300.00 |
| Dec 31, 2024 | 9.96 Mn |
| Jun 30, 2024 | 1,730.00 |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 9.22 Mn |
| Jun 30, 2023 | 320.00 |
| Dec 31, 2022 | 4.99 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 1,790.00 |
| Dec 31, 2021 | 3.89 Mn |
| Dec 31, 2018 | 170.00 |